People · Operator
Named in public records as an officer, director or promoter · active 2009–2018 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Siamab Therapeutics, Inc. | — | Biotechnology | Seed | $8.8M | $29.5M | 2015 |
| Conversion Innovations, Inc. | — | Other Technology | Seed | $5.6M | $71.3M | 2010 |
| TenMarks Education, Inc. | — | Other Technology | Seed | $2.2M | $6.8M | 2009 |
PETER KROON at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside PETER KROON on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Kelly | 1 | 7 |
| Sundar Subramaniam | 1 | 6 |
| Jean Hammond | 1 | 4 |
| Rohit Agarwal | 1 | 3 |
| Jeffrey Behrens | 1 | 3 |
| ANDREW MAILLET | 1 | 2 |
| Adam Blake | 1 | 2 |
| Mark Hattendorf | 1 | 2 |
| Madhav Anand | 1 | 2 |
| NICHOLAS GOGGANS | 1 | 2 |
| Peter F. Kroon | 1 | 1 |
| Andrew F. Joseph | 1 | 1 |
| Jean F. Hammond | 1 | 1 |
| Carl Haney | 1 | 1 |
| Rohit F. Agarwal | 1 | 1 |
| Max Faingezicht | 1 | 1 |
| JOHN PATRICK KELLY | 1 | 1 |
| Ajit Varki | 1 | 1 |
| Nissi Varki | 1 | 1 |
| Brad Curley | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.